13 employees
Cambium develops biomaterials for applications across defense, space, aerospace, and renewable energy.
2019
$8M
from 4 investors over 4 rounds
Cambium raised undisclosed on November 1, 2022
Investors: Susa Ventures and 8VC
Cambium raised $8M on September 14, 2021
Investors: 8VC and Ginkgo Bioworks, Inc.